Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT01706913Not ApplicableCompleted

Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis

Role: collaborator

NCT05147129Completed

Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus

Role: collaborator

NCT02691117Phase 3Terminated

Topical Garlic Concentrate for Alopecia Areata in Children

Role: collaborator

NCT00994240Not ApplicableTerminated

Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC

Role: collaborator

NCT01498406Phase 2Terminated

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Role: collaborator

All 5 trials loaded